Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients

Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients

Background: Diabetes is a risk factor associated with pancreatic ductal adenocarcinoma (PDAC), and new adult-onset diabetes can be an early sign of pancreatic malignancy. Development of blood-based biomarkers to identify diabetic patients who warrant imaging tests for cancer detection may represent...

Full description

Bibliographic Details
Main Authors: Hong Peng, Sheng Pan, Yuanqing Yan, Randall E. Brand, Gloria M. Petersen, Suresh T. Chari, Lisa A. Lai, Jimmy K. Eng, Teresa A. Brentnall, Ru Chen
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
proteomics
pancreatic cancer
pancreatic ductal adenocarcinoma
diabetes
mass spectrometry
plasma
Online Access:https://www.mdpi.com/2072-6694/12/6/1534

Internet

https://www.mdpi.com/2072-6694/12/6/1534

Similar Items